Skip to product information
1 of 1

Jant Pharmacal

Accutest Mononucleosis Rapid Test (ID516)

Accutest Mononucleosis Rapid Test (ID516)

Regular price $85.63 USD
Regular price Sale price $85.63 USD
Sale Sold out

⚠️ Back Order Estimated Restock Date:

Order Packaging

1 Box (25 tests/box, including reagents and controls)

Vendor Shipping & Returns

Shipping:
Minimum Order $50.00. Free shipping orders over $800.00 on regular priced items. $17.50 flat rate shipping GND (1-5 BUS DAYS) in continental USA. Exclusions may apply.

Returns:
15% restocking fee, 10% administration fee. Shipping is paid for by the customer. Original packaging. No returns after 30 days.

Not all products are eligible for returns. Exclusions may apply. All returns must be approved by our Returns Department. An e-mail notification will be issued regarding your return status and return instructions, should this apply. Any product returned for credit without an authorized RMA number clearly printed on the outside package or shipping label will be refused. Unauthorized returns will not be honored or accepted for credit.

View full details

SKU: ID516    ACCUTEST Mononucleosis Rapid Test    25 tests/box (including reagents and controls)

Accutest Rapid Mono test is an immunoassay for the Qualitative Detection of Infectious Mononucleosis Heterophile Antibodies in Whole Blood, Serum or Plasma. This test is intended for use as an aid in the diagnosis of infectious mononucleosis.

  • Results in minutes.
  • No age restrictions.
  • CLIA complexity: WAIVED (for whole blood)
  • Cassette format

CPT Code:

  • 86308QW (Whole Blood – CLIA waived)
  • 86308 (Plasma/Serum


Infectious mononucleosis (IM) is an acute, self-limited, lymphoproliferative disease caused by the Epstein-Barr virus (EBV). Infection with EBV usually occurs early in life with no recognizable disease. When primary infection is delayed until young adulthood and adolescence, there is about a 50% chance that it will occur with the classic clinical manifestations associated with IM. The diagnosis of IM is usually based on the evaluation of characteristic clinical, hematological, and serological changes. In most cases of IM, clinical diagnosis can be made from the characteristic triad of fever, pharyngitis, and cervical lymphadenopathy, lasting for 1 to 4 weeks. IM may be complicated by splenomegaly, hepatitis, pericarditis, or central nervous system involvement. Rare fatal primary infections occur in patients with histiocytic hemophagocytic syndrome or with a genetic X-linked lymphoproliferative syndrome. Hematologic features of IM include lymphocytosis with prominent atypical lymphocytes. Because other diseases may mimic the clinical and hematological symptoms of IM, serological testing is essential for the most accurate diagnosis. Serological diagnosis of IM is demonstrated by the presence of heterophile and EBV antibodies in the sera of patients.  It has been well established that most individuals exposed to EBV develop a heterophile antibody response. Heterophile antibodies make up a broad class of antibodies which are characterized by the ability to react with surface antigens present on erythrocytes of different mammalian species. It is not known which specific antigen stimulates their production. It has been a common practice for physicians to use the detection of IM heterophile antibodies in the blood of patients as an aid in the diagnosis of IM. Accutest Rapid Mono assay utilizes an extract of bovine erythrocytes which gives a greater sensitivity and specicity than similar extracts prepared from sheep and horse erythrocytes. The Forssman antibody interference has been known to be minimized by using the bovine erythrocyte extract.

Additional resources:
http://www.cdc.gov/epstein-barr/about-mono.html

Features & Benefits
Results in minutes
No age restrictions
CLIA complexity: WAIVED (for whole blood)
Cassette format
CPT Code: 86308QW (Whole Blood CLIA waived), 86308 (Plasma/Serum)